StonvexLoading…
StonvexStonvexStonvexCore line items from RDDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.20B | $1.30B | $804.03M | $666.70M |
Operating Income | $441.98M | $-560.57M | $-140.16M | $-172.16M |
Net Income | $529.72M | $-484.28M | $-90.82M | $-158.55M |
EPS (Diluted) | $2.62 | $-3.33 | $-1.54 | $-2.77 |
Total Assets | $3.24B | $2.34B | $1.60B | Not available |
Total Liabilities | $310.13M | $205.85M | $155.90M | Not available |
Cash & Equivalents | $953.57M | $562.09M | $401.18M | $435.81M |
Free Cash Flow OCF − CapEx | $684.17M | $215.82M | $-84.84M | $-100.25M |
Shares Outstanding | 202.11M | 145.47M | 59.14M | 57.25M |